Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 54 (1976), S. 303-307 
    ISSN: 1432-1440
    Keywords: Hepatitis B-Antigen ; Lupus erythematodes disseminatus ; Komplementfixation ; Hepatitis B antigen ; Systemic lupus erythematosus ; Complement fixation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Sera from 22 patients with systemic lupus erythematosus (SLE) were examined for the presence of hepatitis B antigen (HBsAg) by a complement fixation (CF) test, by an immunoelectrophoretic method (counterelectrophoresis-CEP), and by radioimmunoassay (RIA). The sera from 8 patients gave positive results using CF. However, the same sera and sera from 28 additional SLE patients, when tested with CEP and RIA, were not shown to contain HBsAg. Additional studies were carried out in order to characterize the factor responsible for the false positive CF of the 8 SLE sera. It was shown that the sera also fixed complement in presence of normal serum previously submitted to freezing and thawing or heating at 65°C. The complement fixing factor was readily absorbed by aggregated IgG but not by insolubilized HBsAg. Complement fixation was strongly diminished by 2-mercaptoethanol treatment of SLE serum. It thus appears that the false positive reactions for the presence of HBsAg obtained by CF are due to the occurrence of “anti-antibodies” reacting with aggregated IgG. There is no increased incidence of HBsAg in the serum of SLE patients.
    Notes: Zusammenfassung Seren von 22 Patienten mit Lupus erythematodes disseminatus (LED) wurden auf das Vorliegen des Hepatitis-B-Antigens (HBsAg) untersucht. Zu diesem Zwecke wurden 3 verschiedene Methoden eingesetzt: 1. Komplement-Fixationstest (KFT), 2. Überwanderungselektrophorese (UEP) und 3. Radio-Immunoassay. Seren von 8 Patienten zeigten positive Resultate im KFT. Dieselben Seren und solche von 28 weiteren LED Patienten enthielten kein HBsAg, wenn sie mit UEP und Radio-Immunoassay getestet wurden. Zusätzliche Studien dienten der Charakterisierung des für den positiven KFT verantwortlichen Faktors. Es zeigte sich, daß die LED Seren auch Komplement in Gegenwart von normalen Seren fixierten, wenn letztere mehrfach gefroren und aufgetaut oder auf 65°C erhitzt worden waren. Der Komplement-fixierende Faktor war absorbierbar mit aggregierten Gammaglobulinen, nicht aber mit HBsAg. Die Komplement fixierende Aktivität des Faktors wurde durch Behandlung der Seren mit 2-Merkapto-Aethanol abgeschwächt. Die falsch positiven Komplement-Fixationsteste mit LED Seren und anti HBsAg Antiseren können demzufolge auf das Vorliegen von Anti-Antikörpern mit Gammaglobulinspezifität zurÜckgeführt werden.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1912
    Keywords: Serotonin release ; Raphe nuclei ; Monoamine oxidase inhibitors ; Intracerebral microdialysis ; Antidepressants
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary We have examined the local and systemic effects of clorgyline, tranylcypromine and deprenyl on extracellular serotonin (5-HT) and 5-hydroxyindoleacetic acid in the raphe nuclei and in frontal cortex of awake, freely-moving rats using microdialysis. When administered through the dialysis probe, monoamine oxidase (monoamine: oxygen oxidoreductase (deaminating), E.C. 1.4.3.4., MAO) inhibitors increased 5-HT output in a dose-dependent manner in both brain areas. The effects were more pronounced in the raphe nuclei for the three MAO inhibitors at all doses assayed. When the monoamine oxidase inhibitors were given i.p., dialysate 5-HT increased dramatically, after tranylcypromine (15 mg/kg), in raphe nuclei and frontal cortex (area under the curve (AUC) to 4 h post-treatment: 63-fold and 11-fold, respectively) whereas the effects of clorgyline (10 mg/kg) were much less pronounced (+ 47% increase in the AUC for raphe nuclei, P 〈 0.09; + 18% increase in the AUC for frontal cortex, n.s.). Deprenyl (2.5 mg/kg, i.p.) induced a moderate (+ 22%) increase of dialysate 5-HT from the raphe nuclei but did not cause a change in dialysate 5-HT from the frontal cortex (+ 4%). However, clorgyline, or deprenyl, dramatically increased dialysate 5-HT in animals which had been pre-treated with the above dose of deprenyl, or clorgyline, respectively, showing that the blockade of both forms of MAO results in much larger increases of extracellular 5-HT than does the blockade of either form alone. These results indicate that: (a) deamination by MAO participates actively in the control of the extracellular concentration of 5-HT in those areas of the brain that are rich in serotoninergic nerve terminals as well as in cell bodies, (b) in vivo, brain 5-HT is deaminated preferentially by MAO-A but its full inhibition does not result in an increased release of 5-HT, in spite of a large accumulation of 5-HT in the brain tissue, (c) MAO-B deaminates 5-HT when the A-form is inhibited (in this situation, MAO-B participates actively in the control of a releasable pool of 5-HT), (d) the raphe nuclei appears to be a preferential site of action of MAO inhibitors, administered either locally or systemically. These results may help to understand the model of action of MAO inhibitors as antidepressant drugs.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...